IDDI at CNS Therapeutics Xchange 2024

June 24, 2024

Boston, MA

IDDI team is excited to attend CNS Therapeutics Xchange 2024 and present a poster about new FDA guidance on DMCs!

Kirby Morgan – Senior Biostatistician, IDDI has presented a poster entitled:

New FDA Guidance on Data Monitoring Committees (DMCs) and Recommended Unblinded Data Reporting Practices for Effective Clinical Trial Oversight




IDDI is an expert clinical data services and high-level strategic consulting contract research organization (CRO). Our teams provide agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies. With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.

We are committed to providing quality, submission-ready clinical data, thanks to a unique combination of methodological excellence and operational efficiency. 

About the event:

CNS Therapeutics Xchange Boston 2024 brings together executives from pharma and biotech to address and find solutions to the key issues faced in CNS Therapeutics. View agenda and other information about the event here.